Stockchase Opinions

Benj Gallander Medisolution MSH-T BUY Sep 21, 2007

Health technology industry. They are a leader in Canada, but have a lot of US competition. Tremendous backers, so have very deep pockets. Seems to be a classic turn around situation. Could see it doubling, but could take a while.
$0.175

Stock price when the opinion was issued

medical services
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

DON'T BUY
Interesting company, but can't see any cash flow yet, so not interested
DON'T BUY
This sector is a great space. This stock has broken below its 200 day moving average. Earnings growth is slow. Check out competition and buy them.
COMMENT
Deals with healthcare and are backed by Brascan. Very deep pockets. Over $40 million in revenues. They are on the cusp of profitability. A classic contrarian pick.
BUY
He is quite content to sit with this one. They can't seem to make money, but they are leaders in the health sector. Have deep pockets behind them. Brascan is a major shareholder.
BUY
Healthcare market is very competitive. Very difficult to make money on a consistent basis. This company went through a very difficult period and have to do some restructuring in order to get things more under control. They seem to be coming out of that d
COMMENT
Backed by some very big players. Company has done almost nothing for a long period of time but he is happy to hold it. Whenever dealing with smaller software players there is always a danger.